Lifestyle Risk Factors for Serrated Colorectal Polyps: A Systematic Review and Meta-analysis

Gastroenterology

Volumn 152, Issue 1, 2017, Pages 92-104

  Bailie, Lesley ^a   Loughrey, Maurice B ^b   Coleman, Helen G ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Colon Cancer; Epidemiology; NSAIDs; Nutrition

Indexed keywords

ACETYLSALICYLIC ACID; CALCIUM; FOLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ALCOHOL CONSUMPTION; ARTICLE; BODY FAT; BODY MASS; CALCIUM INTAKE; COLORECTAL POLYP; DIET; DIETARY FIBER; DISEASE ASSOCIATION; DRUG USE; HORMONE SUBSTITUTION; HUMAN; LIFESTYLE; LIPID DIET; MEAT; PATHOGENESIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RECTUM ADENOMA; SERRATED COLORECTAL POLYP; SMOKING; SYSTEMATIC REVIEW; VITAMIN INTAKE; ADENOMA; COLON; COLONIC POLYPS; DRINKING BEHAVIOR; EXERCISE; HYPERPLASIA; META ANALYSIS; PATHOLOGY; PROTECTION; RECTAL DISEASES; RECTUM; RISK FACTOR;

ADENOMA; ALCOHOL DRINKING; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BODY MASS INDEX; COLON; COLONIC POLYPS; DIET; EXERCISE; HUMANS; HYPERPLASIA; LIFE STYLE; PROTECTIVE FACTORS; RECTAL DISEASES; RECTUM; RISK FACTORS; SMOKING;

EID: 85006321116     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.09.003     Document Type: Article

References (88)

1. 1 Binefa, G., Rodriguez-Moranta, F., Teule, A., et al. Colorectal cancer: from prevention to personalized medicine. World J Gastroenterol 20 (2014), 6786–6808.
2. 2 Torre, L.A., Bray, F., Siegel, R.L., et al. Global cancer statistics, 2012. CA Cancer J Clin 65 (2015), 87–108.
3. 3 Ferlay, J., Soerjomataram, I., Dikshit, R., et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136 (2015), E359–E386.
4. 4 Cancer Research UK. Cancer statistics key facts−bowel cancer. Available at: http://publications.cancerresearchuk.org/downloads/product/CS_KF_BOWEL.pdf. Accessed October 7, 2014.
5. 5 Platz, E.A., Willett, W.C., Colditz, G.A., et al. Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men. Cancer Causes Control 11 (2000), 579–588.
6. 6 Tateyama, H., Li, W., Takahashi, E., et al. Apoptosis index and apoptosis-related antigen expression in serrated adenoma of the colorectum: the saw-toothed structure may be related to inhibition of apoptosis. Am J Surg Pathol 26 (2002), 249–256.
7. 7 Leggett, B., Whitehall, V., Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology 138 (2010), 2088–2100.
8. 8 Torlakovic, E., Skovlund, E., Snover, D.C., et al. Morphologic reappraisal of serrated colorectal polyps. Am J Surg Pathol 27 (2003), 65–81.
9. 9 Kim, S.W., Cha, J.M., Lee, J.I., et al. A significant number of sessile serrated adenomas might not be accurately diagnosed in daily practice. Gut Liver 4 (2010), 498–502.
10. 10 Rex, D.K., Ahnen, D.J., Baron, J.A., et al. Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol 107 (2012), 1315–1329.
11. 11 Szylberg, L., Janiczek, M., Popiel, A., et al. Serrated polyps and their alternative pathway to the colorectal cancer: a systematic review. Gastroenterol Res Pract, 2015, 2015, 573814.
12. 12 Gill, P., Rafferty, H., Munday, D., et al. Proximal colon cancer and serrated adenomas - hunting the missing 10%. Clin Med 13 (2013), 557–561.
13. 13 Patai, A.V., Molnar, B., Tulassay, Z., et al. Serrated pathway: alternative route to colorectal cancer. World J Gastroenterol 19 (2013), 607–615.
14. 14 Yamane, L., Scapulatempo-Neto, C., Reis, R.M., et al. Serrated pathway in colorectal carcinogenesis. World J Gastroenterol 20 (2014), 2634–2640.
15. 15 Snover, D.C., Update on the serrated pathway to colorectal carcinoma. Hum Pathol 42 (2011), 1–10.
16. 16 Gao, Q., Tsoi, K.K., Hirai, H.W., et al. Serrated polyps and the risk of synchronous colorectal advanced neoplasia: a systematic review and meta-analysis. Am J Gastroenterol 110 (2015), 501–509.
17. 17 Botteri, E., Iodice, S., Raimondi, S., et al. Cigarette smoking and adenomatous polyps: a meta-analysis. Gastroenterology 134 (2008), 388–395.
18. 18 Ben, Q., An, W., Jiang, Y., et al. Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology 142 (2012), 762–772.
19. 19 Cole, B.F., Logan, R.F., Halabi, S., et al. Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst 101 (2009), 256–266.
20. 20 Haque, T.R., Bradshaw, P.T., Crockett, S.D., Risk factors for serrated polyps of the colorectum. Dig Dis Sci 59 (2014), 2874–2889.
21. 21 World Cancer Research Fund, American Institute for Cancer Research. Continuous Update Project Report. Food, Nutrition, Physical Activity, and the Prevention of Colorectal Cancer. 2011, World Cancer Research Fund, American Institute for Cancer Research, Washington DC.
22. 22 Wang, Y.M., Zhou, Q.Y., Zhu, J.Z., et al. Systematic review with meta-analysis: alcohol consumption and risk of colorectal serrated polyp. Dig Dis Sci 60 (2015), 1889–1902.
23. 23 Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed November 22, 2015.
24. 24 Qazi, T.M., O'Brien, M.J., Farraye, F.A., et al. Epidemiology of goblet cell and microvesicular hyperplastic polyps. Am J Gastroenterol 109 (2014), 1922–1932.
25. 25 Wallace, K., Grau, M.V., Ahnen, D., et al. The association of lifestyle and dietary factors with the risk for serrated polyps of the colorectum. Cancer Epidemiol Biomarkers Prev 18 (2009), 2310–2317.
26. 26 Higgins, J.P., Thompson, S.G., Deeks, J.J., et al. Measuring inconsistency in meta-analyses. BMJ 327 (2003), 557–560.
27. 27 Sterne, J.A., Egger, M., Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 54 (2001), 1046–1055.
28. 28 Burnett-Hartman, A.N., Newcomb, P.A., Mandelson, M.T., et al. Colorectal polyp type and the association with charred meat consumption, smoking, and microsomal epoxide hydrolase polymorphisms. Nutr Cancer 63 (2011), 583–592.
29. 29 Burnett-Hartman, A.N., Passarelli, M.N., Adams, S.V., et al. Differences in epidemiologic risk factors for colorectal adenomas and serrated polyps by lesion severity and anatomical site. Am J Epidemiol 177 (2013), 625–637.
30. 30 Crockett, S., Martin, C., Snover, D., et al. Differences in risk factors among those with serrated polyps, sessile serrated adenomas, and conventional adenomas. Am J Gastroenterol 109 (2014), S615–S616.
31. 31 Davenport, J., Smalley, W.E., Su, Y., et al. Contributions of cigarette smoking to the development of sessile serrated adenomas in a distinct population. Gastroenterology 146:Suppl (2014), S175–S176.
32. 32 Erhardt, J.G., Kreichgauer, H.P., Meisner, C., et al. Alcohol, cigarette smoking, dietary factors and the risk of colorectal adenomas and hyperplastic polyps—a case control study. Eur J Nutr 41 (2002), 35–43.
33. 33 Figueiredo, J.C., Crockett, S.D., Snover, D.C., et al. Smoking-associated risks of conventional adenomas and serrated polyps in the colorectum. Cancer Causes Control 26 (2015), 377–386.
34. 34 Hassan, C., Pickhardt, P.J., Marmo, R., et al. Impact of lifestyle factors on colorectal polyp detection in the screening setting. Dis Colon Rectum 53 (2010), 1328–1333.
35. 35 Hirai, H., Ng, S., Ching, J., et al. Serrated lesions share common risk factors with colonic advanced neoplasms in 6,218 Chinese cohort. J Gastroenterol Hepatol, 28, 2013, 555.
36. 36 Hoffmeister, M., Schmitz, S., Karmrodt, E., et al. Male sex and smoking have a larger impact on the prevalence of colorectal neoplasia than family history of colorectal cancer. Clin Gastroenterol Hepatol 8 (2010), 870–876.
37. 37 Ji, B.T., Weissfeld, J.L., Chow, W.H., et al. Tobacco smoking and colorectal hyperplastic and adenomatous polyps. Cancer Epidemiol Biomarkers Prev 15 (2006), 897–901.
38. 38 Kearney, J., Giovannucci, E., Rimm, E.B., et al. Diet, alcohol, and smoking and the occurrence of hyperplastic polyps of the colon and rectum (United States). Cancer Causes Control 6 (1995), 45–56.
39. 39 Lai, S., Liao, K., Body mass index and colorectal hyperplastic polyps. Am J Gastroenterol, 108, 2013, 280.
40. 40 Lieberman, D.A., Prindiville, S., Weiss, D.G., et al. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. J Am Med Assoc 290 (2003), 2959–2967.
41. 41 Martinez, F., Fernandez-Martos, C., Quintana, M.J., et al. APC and KRAS mutations in distal colorectal polyps are related to smoking habits in men: results of a cross-sectional study. Clin Transl Oncol 13 (2011), 664–671.
42. 42 Martinez, M.E., McPherson, R.S., Levin, B., et al. A case-control study of dietary intake and other lifestyle risk factors for hyperplastic polyps. Gastroenterology 113 (1997), 423–429.
43. 43 Michal, S., Li, L., Chen, Z., Lifestyle and dietary risk factors for colorectal hyperplastic and adenomatous polyps. Cancer Epidemiol Biomarkers Prev, 21, 2012, 563.
44. 44 Morimoto, L.M., Newcomb, P.A., Ulrich, C.M., et al. Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential?. Cancer Epidemiol Biomarkers Prev 11 (2002), 1012–1018.
45. 45 Noreen, F., Roosli, M., Gaj, P., et al. Modulation of age- and cancer-associated DNA methylation change in the healthy colon by aspirin and lifestyle. J Natl Cancer Inst(7), 2014, 106.
46. 46 Omata, F., Brown, W.R., Tokuda, Y., et al. Modifiable risk factors for colorectal neoplasms and hyperplastic polyps. Intern Med 48 (2009), 123–128.
47. 47 Oza, V., Behzadi, J., Moore, S.A., et al. Endoscopist specialty and withdrawal time impact the detection rate of proximal serrated polyps. Gastroenterology, 146(Suppl 1), 2014, S-728.
48. 48 Wang, F., Hsu, P., Chuang, H., et al. Prevalence and risk factors of asymptomatic colorectal polyps in Taiwan. Gastroenterol Res Pract, 2014, 2014, 985205.
49. 49 Yoshida, I., Suzuki, A., Vallee, M., et al. Serum insulin levels and the prevalence of adenomatous and hyperplastic polyps in the proximal colon. Clin Gastroenterol Hepatol 4 (2006), 1225–1231.
50. 50 Drew, D.A., Goh, G., Mo, A., et al. Colorectal polyp prevention by daily aspirin use is abrogated among active smokers. Cancer Causes Control 27 (2016), 93–103.
51. 51 Anderson, J.C., Rangasamy, P., Rustagi, T., et al. Risk factors for sessile serrated adenomas. J Clin Gastroenterol 45 (2011), 694–699.
52. 52 Buda, A., De Bona, M., Dotti, I., et al. Prevalence of different subtypes of serrated polyps and risk of synchronous advanced colorectal neoplasia in average-risk population undergoing first-time colonoscopy. Clin Transl Gastroenterol, 3, 2012, e6.
53. 53 Randles, J., Hum, J., Addante, R.A., et al. Risk factors for the development of sessile serrated polyps. Gastroenterology, 148(Suppl), 2015, S761.
54. 54 Fu, Z., Shrubsole, M.J., Smalley, W.E., et al. Lifestyle factors and their combined impact on the risk of colorectal polyps. Am J Epidemiol 176 (2012), 766–776.
55. 55 Crockett, S.D., Martin, C.F., Baron, J.A., et al. Obesity, waist-hip-ratio, diet, and physical activity and risk of serrated polyps and sessile serrated adenomas: a cross-sectional study. Gastroenterology 148:Suppl (2015), S670–S671.
56. 56 Butterly, L., Robinson, C.M., Anderson, J.C., et al. Serrated and adenomatous polyp detection increases with longer withdrawal time: results from the New Hampshire Colonoscopy Registry. Am J Gastroenterol 109 (2014), 417–426.
57. 57 Leitzmann, M.F., Flood, A., Ferrucci, L.M., et al. Adiposity in relation to colorectal adenomas and hyperplastic polyps in women. Cancer Causes Control 20 (2009), 1497–1507.
58. 58 Liu, C.S., Hsu, H.S., Li, C.I., et al. Central obesity and atherogenic dyslipidemia in metabolic syndrome are associated with increased risk for colorectal adenoma in a Chinese population. BMC Gastroenterol, 10, 2010, 51.
59. 59 Liu, J., Pattanaik, S., Yao, J., et al. Associations among pericolonic fat, visceral fat, and colorectal polyps on CT colonography. Obesity 23 (2015), 408–414.
60. 60 Wallace, K., Baron, J.A., Karagas, M.R., et al. The association of physical activity and body mass index with the risk of large bowel polyps. Cancer Epidemiol Biomarkers Prev 14 (2005), 2082–2086.
61. 61 Johnson, C.C., Hayes, R.B., Schoen, R.E., et al. Non-steroidal anti-inflammatory drug use and colorectal polyps in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Am J Gastroenterol 105 (2010), 2646–2655.
62. 62 Murff, H.J., Shrubsole, M.J., Chen, Z., et al. Nonsteroidal anti-inflammatory drug use and risk of adenomatous and hyperplastic polyps. Cancer Prev Res (Phila Pa) 4 (2011), 1799–1807.
63. 63 Adams, S.V., Newcomb, P.A., Burnett-Hartman, A.N., et al. Circulating 25-hydroxyvitamin-D and risk of colorectal adenomas and hyperplastic polyps. Nutr Cancer 63 (2011), 319–326.
64. 64 Dai, Q., Shrubsole, M.J., Ness, R.M., et al. The relation of magnesium and calcium intakes and a genetic polymorphism in the magnesium transporter to colorectal neoplasia risk. Am J Clin Nutr 86 (2007), 743–751.
65. 65 Fu, Z., Shrubsole, M.J., Smalley, W.E., et al. Association of meat intake and meat-derived mutagen exposure with the risk of colorectal polyps by histologic type. Cancer Prev Res (Phila Pa) 4 (2011), 1686–1697.
66. 66 Murff, H.J., Shrubsole, M.J., Cai, Q., et al. Dietary intake of PUFAs and colorectal polyp risk. Am J Clin Nutr 95 (2012), 703–712.
67. 67 Platz, E.A., Giovannucci, E., Rimm, E.B., et al. Dietary fiber and distal colorectal adenoma in men. Cancer Epidemiol Biomarkers Prev 6 (1997), 661–670.
68. 68 Poole, E.M., Bigler, J., Whitton, J., et al. Genetic variability in prostaglandin synthesis, fish intake and risk of colorectal polyps. Carcinogenesis 28 (2007), 1259–1263.
69. 69 Carr, N.J., Mahajan, H., Tan, K.L., et al. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol 62 (2009), 516–518.
70. 70 Limsui, D., Vierkant, R.A., Tillmans, L.S., et al. Cigarette smoking and colorectal cancer risk by molecularly defined subtypes. J Natl Cancer Inst 102 (2010), 1012–1022.
71. 71 Lee, P.N., Forey, B.A., Indirectly estimated absolute lung cancer mortality rates by smoking status and histological type based on a systematic review. BMC Cancer, 13, 2013, 189.
72. 72 Pohl, H., Wrobel, K., Bojarski, C., et al. Risk factors in the development of esophageal adenocarcinoma. Am J Gastroenterol 108 (2013), 200–207.
73. 73 Varela-Rey, M., Woodhoo, A., Martinez-Chantar, M.L., et al. Alcohol, DNA methylation, and cancer. Alcohol Res 35 (2013), 25–35.
74. 74 Bergmann, M.M., Rehm, J., Klipstein-Grobusch, K., et al. The association of pattern of lifetime alcohol use and cause of death in the European prospective investigation into cancer and nutrition (EPIC) study. Int J Epidemiol 42 (2013), 1772–1790.
75. 75 Moon, J.W., Lee, S.K., Lee, Y.W., et al. Alcohol induces cell proliferation via hypermethylation of ADHFE1 in colorectal cancer cells. BMC Cancer, 14, 2014, 377.
76. 76 Seitz, H.K., Meier, P., The role of acetaldehyde in upper digestive tract cancer in alcoholics. Transl Res 149 (2007), 293–297.
77. 77 Trayhurn, P., Beattie, J.H., Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc 60 (2001), 329–339.
78. 78 Erlinger, T.P., Platz, E.A., Rifai, N., et al. C-reactive protein and the risk of incident colorectal cancer. JAMA 291 (2004), 585–590.
79. 79 Tsilidis, K.K., Branchini, C., Guallar, E., et al. C-reactive protein and colorectal cancer risk: a systematic review of prospective studies. Int J Cancer 123 (2008), 1133–1140.
80. 80 Keimling, M., Renehan, A.G., Behrens, G., et al. Comparison of associations of body mass index, abdominal adiposity, and risk of colorectal cancer in a large prospective cohort study. Cancer Epidemiol Biomarkers Prev 22 (2013), 1383–1394.
81. 81 Wernli, K.J., Newcomb, P.A., Wang, Y., et al. Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polyps. Growth Horm IGF Res 20 (2010), 305–309.
82. 82 Friedenreich, C.M., Orenstein, M.R., Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr 132 (2002), 3456S–3464S.
83. 83 Wolin, K.Y., Yan, Y., Colditz, G.A., Lee, I.M., Physical activity and colon cancer prevention: a meta-analysis. Br J Cancer 100 (2009), 611–616.
84. 84 Johnson, C.M., Wei, C., Ensor, J.E., et al. Meta-analyses of colorectal cancer risk factors. Cancer Causes Control 24 (2013), 1207–1222.
85. 85 Nanda, K., Bastian, L.A., Hasselblad, V., et al. Hormone replacement therapy and the risk of colorectal cancer: a meta-analysis. Obstet Gynecol 93 (1999), 880–888.
86. 86 Jung, A.Y., Poole, E.M., Bigler, J., et al. DNA methyltransferase and alcohol dehydrogenase: gene-nutrient interactions in relation to risk of colorectal polyps. Cancer Epidemiol Biomarkers Prev 17 (2008), 330–338.
87. 87 Fu, Z., Shrubsole, M.J., Li, G., et al. Interaction of cigarette smoking and carcinogen-metabolizing polymorphisms in the risk of colorectal polyps. Carcinogenesis 34 (2013), 779–786.
88. 88 Snover, D.C., Ahnen, D.J., Burt, R.W., et al. Serrated polyps of the colon and rectum and serrated polyposis. Bosman, F.T., Carneiro, F., Hruban, R.H., et al. (eds.) WHO Classification of Tumours of the Digestive System, 4th ed., 2010, IARC Press, Lyon.